Jul 21, 2026 07:29AM
Jul 21, 2026 03:25AM
May 7, 2026 09:01AM
May 7, 2026 09:00AM
Apr 30, 2026 07:01AM
Apr 30, 2026 07:00AM
Oct 28, 2025 02:41AM Novartis (NVS) Misses Q3 EPS by 2c; offers outlook
Oct 27, 2025 04:00PM
Sep 29, 2025 07:32AM
Sep 12, 2025 12:55AM
Jul 17, 2025 03:19AM
Apr 29, 2025 03:43AM
Apr 28, 2025 11:34AM
Apr 16, 2025 10:15AM BNP Paribas Exane Starts Novartis (NOVN:SW) (NVS) at Outperform
Feb 12, 2025 05:46AM
Jan 31, 2025 02:10AM
Jan 31, 2025 01:14AM
Oct 29, 2024 04:40AM
Oct 28, 2024 07:01AM
Sep 27, 2024 09:28AM
Sep 11, 2024 05:38AM Novartis shares slide on BofA downgrade
Sep 11, 2024 12:44AM
Sep 5, 2024 08:32AM
Sep 5, 2024 02:43AM
Sep 5, 2024 02:42AM
Jul 30, 2024 07:00AM
Jul 18, 2024 06:50AM
Jul 18, 2024 02:59AM Novartis (NVS) Tops Q2 EPS by 13c; offers outlook
May 30, 2024 10:26AM
May 30, 2024 03:29AM
May 7, 2024 07:00AM
Apr 23, 2024 01:11PM
Apr 23, 2024 04:25AM
Feb 12, 2024 06:01AM
Feb 5, 2024 04:58PM After-hours movers: Palantir, NXP Semiconductors and more
Feb 5, 2024 11:47AM
Jan 31, 2024 07:30AM
Jan 31, 2024 06:05AM
Oct 24, 2023 06:47AM
Oct 24, 2023 01:11AM
Oct 4, 2023 09:22AM
Sep 14, 2023 09:23AM This pharma 'growth' stock trades at 'value' price - BofA
Jul 18, 2023 08:18AM
Jul 18, 2023 05:38AM
Jul 18, 2023 05:33AM
Jul 18, 2023 05:23AM
Jul 18, 2023 01:26AM
Jun 30, 2023 08:20AM
Jun 30, 2023 07:12AM Bausch + Lomb buys Novartis drugs for $1.75 billion to boost eye-care portfolio
May 4, 2023 04:01PM

1,206,250 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All